Abstract
BackgroundSurgical site infection (SSI) is a common postoperative complication. We aimed to analyze the potential risk factors of SSI in patients with endometrial carcinoma.MethodsPatients with endometrial carcinoma who underwent surgery treatment in our hospital from Sept 1, 2018 to August 31, 2020 were included. We retrospectively compared the characteristics of SSI and no SSI patients, and logistic regression analyses were performed to identify the risk factors of SSI in patients with endometrial carcinoma.ResultsA total of 318 postoperative patients with endometrial carcinoma were included. The incidence of SSI in patients with endometrial carcinoma was 14.47 %. There were significant differences on the FIGO stage, type of surgery, durations of drainage, postoperative serum albumin and postoperative blood sugar (all p < 0.05), and no significant differences on the age, BMI, hypertension, diabetes, hyperlipidemia, estimated blood loss, length of hospital stay were found (all p > 0.05). FIGO stage IV (HR3.405, 95 %CI 2.132–5.625), open surgery (HR2.692, 95 %CI 1.178–3.454), durations of drainage ≥ 7 d (HR2.414,95 %CI 1.125–2.392), postoperative serum albumin < 30 g/L (HR1.912,95 %CI 1.263–2.903), postoperative blood sugar ≥ 10 mmol/L (HR1.774,95 %CI 1.102–2.534) were the independent risk factors of SSI in patients with endometrial carcinoma (all p < 0.05).ConclusionsMeasures including reasonable control of serum albumin and blood glucose levels, minimally invasive surgery as much as possible, timely assessment of drainage and early removal of the tube may be beneficial to reduce the postoperative SSI in in patients with endometrial carcinoma.
Highlights
Surgical site infection (SSI) is a common postoperative complication
We conducted a retrospective analysis targeted on patients with endometrial carcinoma undergoing surgical treatment, and we analyzed the distribution of pathogenic bacteria and related factors of postoperative SSI, to provide evidence support for the effective prevention and control of SSI in patients with endometrial carcinoma, thereby providing insights into the management of endometrial carcinoma
There were significant differences on the Federation of Obstetrics and Gynecology (FIGO) stage, type of surgery, durations of drainage, postoperative serum albumin and postoperative blood sugar between two groups(all p < 0.05), the patients with FIGO stage IV, open surgery, durations of drainage ≥ 7d, postoperative serum albumin < 30 g/L and postoperative blood sugar ≥ 10 mmol/L in SSI group were significant more than that of no-SSI group, indicating that e FIGO stage, type of surgery, durations of drainage, postoperative serum albumin and postoperative blood sugar might be associated with the onset and development of SSI in patients with endometrial carcinoma
Summary
Surgical site infection (SSI) is a common postoperative complication. We aimed to analyze the potential risk factors of SSI in patients with endometrial carcinoma. The incidence of endometrial carcinoma has been increased and it is the third common. It has been reported that the incidence of surgical site infection (SSI) is rather high in patients with endometrial carcinomas [8]. There are few clinical studies on the factors related to SSI after endometrial carcinoma surgery. We conducted a retrospective analysis targeted on patients with endometrial carcinoma undergoing surgical treatment, and we analyzed the distribution of pathogenic bacteria and related factors of postoperative SSI, to provide evidence support for the effective prevention and control of SSI in patients with endometrial carcinoma, thereby providing insights into the management of endometrial carcinoma
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call